Extension Study Evaluating The Safety And Tolerability of AMX0035

Clinical trial NCT05619783 · COMPLETED

Trial details

NCT number: NCT05619783
Sponsor: Amylyx Pharmaceuticals Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2022-12-29
Primary completion: 2024-10-16
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.